-
1
-
-
0242285687
-
The statin wars: Why AstraZeneca must retreat
-
The statin wars: why AstraZeneca must retreat. Lancet 2003; 362: 1341.
-
(2003)
Lancet
, vol.362
, pp. 1341
-
-
-
2
-
-
39449119065
-
-
http://www.theheart.org/viewArticle.do?simpleName=565920. Assessed 10.01.2008.
-
-
-
-
3
-
-
2442706279
-
a bad decision for public health
-
OTC statins
-
OTC statins: a bad decision for public health. Lancet 2004; 363: 1659.
-
(2004)
Lancet
, vol.363
, pp. 1659
-
-
-
4
-
-
1542314891
-
Current overview of statin-induced myopathy
-
Rosenson RS. Current overview of statin-induced myopathy. Am J Med 2004; 116: 408-16.
-
(2004)
Am J Med
, vol.116
, pp. 408-416
-
-
Rosenson, R.S.1
-
5
-
-
0030972796
-
The rule of 5 and the rule of 7 in lipid-lowering by statin drugs
-
Roberts WC. The rule of 5 and the rule of 7 in lipid-lowering by statin drugs. Am J Cardiol 1997; 80: 106-7.
-
(1997)
Am J Cardiol
, vol.80
, pp. 106-107
-
-
Roberts, W.C.1
-
6
-
-
39449137694
-
Statins
-
Taylor & Francis, Boca Raton, FL, USA
-
von Haehling S, Anker SD. Statins. In: Hofbauer KG, Anker SD, Inui A, Nicholson JR. Pharmacotherapy of cachexia. Taylor & Francis, Boca Raton, FL, USA 2006; 425-50.
-
(2006)
Hofbauer KG, Anker SD, Inui A, Nicholson JR. Pharmacotherapy of cachexia
, pp. 425-450
-
-
von Haehling, S.1
Anker, S.D.2
-
7
-
-
34250644100
-
Reverse epidemiology beyond dialysis patients: Chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS
-
Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial 2007; 20: 549-53.
-
(2007)
Semin Dial
, vol.20
, pp. 549-553
-
-
Horwich, T.B.1
Fonarow, G.C.2
-
8
-
-
39449117630
-
The endotoxin-lipoprotein hypothesis - an update
-
Sandek A, Utchill S, Rauchhaus M. The endotoxin-lipoprotein hypothesis - an update. Arch Med Sci 2007; 3 (4A): S81-S90.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Sandek, A.1
Utchill, S.2
Rauchhaus, M.3
-
9
-
-
39449086382
-
Cardiovascular risk factors. Lipids and life style changes
-
Höfer J, Niebauer J. Cardiovascular risk factors. Lipids and life style changes. Arch Med Sci 2007; 3 (4A): S69-S73.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Höfer, J.1
Niebauer, J.2
-
10
-
-
39449131074
-
Lipids in ageing and chronic illness: Impact on survival
-
Kovesdy CP, Kalantar-Zadeh K. Lipids in ageing and chronic illness: impact on survival. Arch Med Sci 2007; 3 (4A): S74-S80.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Kovesdy, C.P.1
Kalantar-Zadeh, K.2
-
11
-
-
39449107703
-
Role of statin therapy in the management of patients with the metabolic syndrome
-
Dembowski E, Davidson MH. Role of statin therapy in the management of patients with the metabolic syndrome. Arch Med Sci 2007; 3 (4A): S102-S108.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Dembowski, E.1
Davidson, M.H.2
-
12
-
-
39449133618
-
The current role of statins in acute coronary syndrome
-
Kumar A, Cannon CP. The current role of statins in acute coronary syndrome. Arch Med Sci 2007; 3 (4A): S115-S125.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Kumar, A.1
Cannon, C.P.2
-
15
-
-
39449133304
-
Challenges in trials evaluating statins in heart failure
-
Krum H. Challenges in trials evaluating statins in heart failure. Arch Med Sci 2007; 3 (4A): S142-S146.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Krum, H.1
-
16
-
-
39449132716
-
The significance of statins use in patients subjected to surgical coronary revascularization
-
Banach M, Mikhailidis DP, Ugurlucan M, et al. The significance of statins use in patients subjected to surgical coronary revascularization. Arch Med Sci 2007; 3 (4A): S126-S132.
-
(2007)
Arch Med Sci
, vol.3
, Issue.4 A
-
-
Banach, M.1
Mikhailidis, D.P.2
Ugurlucan, M.3
|